)
Edge26 Jun 2026
The Universal Language: Inventing the Barcode
How lines in the sand on a Miami beach became the most scanned symbol in human history, and why it took decades for anyone to care.
Akari Therapeutics
Akari Therapeutics (AKTX) investor relations material
Akari Therapeutics Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary8 Jul, 2026
Company overview and business model
Incorporated in England and Wales, operates as a public company with limited liability.
Principal executive offices located in Tampa, Florida, with a focus on biopharmaceutical development.
Management team and governance
President and CEO is Abizer Gaslightwala, with a board including medical and financial professionals.
Board resolutions and shareholder authorizations were obtained for recent share and warrant issuances.
Offering details and pricing
Registration covers resale of up to 5,999,999 ADSs, representing up to 479,999,920,000 ordinary shares.
ADSs issued or issuable from private placements and exercise of pre-funded, Series H, I, and J warrants.
Each ADS represents 80,000 ordinary shares.
Exercise price for warrants is $3.74 per ADS, subject to adjustment.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Akari Therapeutics
- Novel ADC platform with immune-activating PH1 payload shows strong preclinical synergy with checkpoint inhibitors.AKTX
Webull Corporate Connect: Virtual Biotech Investment Webinar8 Jul 2026 - Pre-revenue biotech registers resale of 5.99M ADSs; proceeds from warrants to fund R&D.AKTXRegistration filing2 Jul 2026
- Preclinical oncology firm seeks up to $25M via ADS sales to fund R&D, with high dilution risk.AKTXRegistration filing26 Jun 2026
- Comprehensive AGM proxy covers governance, compensation, and major share issuance proposals.AKTXProxy filing4 Jun 2026
- Comprehensive AGM proxy covers governance, compensation, and major capital authorizations.AKTXProxy filing22 May 2026
- Q1 2026 net loss surged to $14.5M due to major impairment charges; urgent funding needed.AKTXQ1 202619 May 2026
- Highly dilutive best efforts offering seeks up to $6.7M for oncology R&D and operations.AKTXRegistration filing8 May 2026
- Net loss decreased to $17.3M in 2025; cash runway into April 2026, further funding required.AKTXQ4 202530 Mar 2026
- AKTX-101 leverages novel PH1 payloads for superior efficacy and safety in Trop-2 cancers.AKTXCorporate presentation13 Feb 2026
Next Akari Therapeutics earnings date
Q2 202618 Aug, 2026
Akari Therapeutics
Next Akari Therapeutics earnings date
Q2 202618 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage